GSA Capital Partners’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-10,300
| Closed | -$42K | – | 2079 |
|
|
2018
Q1 | $42K | Buy |
+10,300
| New | +$42K | ﹤0.01% | 1561 |
|
|
2016
Q2 | – | Sell |
-47,664
| Closed | -$223K | – | 2008 |
|
|
2016
Q1 | $223K | Sell |
47,664
-21,712
| -31% | -$102K | 0.01% | 1447 |
|
|
2015
Q4 | $350K | Buy |
69,376
+44,236
| +176% | +$223K | 0.02% | 1378 |
|
|
2015
Q3 | $88K | Buy |
25,140
+13,840
| +122% | +$48.4K | ﹤0.01% | 1666 |
|
|
2015
Q2 | $113K | Sell |
11,300
-52,637
| -82% | -$526K | ﹤0.01% | 1866 |
|
|
2015
Q1 | $814K | Buy |
+63,937
| New | +$814K | 0.03% | 1035 |
|
|
2014
Q2 | – | Sell |
-19,062
| Closed | -$325K | – | 2047 |
|
|
2014
Q1 | $325K | Buy |
+19,062
| New | +$325K | 0.02% | 1066 |
|
|
2013
Q4 | – | Sell |
-43,916
| Closed | -$444K | – | 1842 |
|
|
2013
Q3 | $444K | Buy |
+43,916
| New | +$444K | 0.04% | 876 |
|